Inicio » Eventos » Congresos SEMA » 2024 SEMA
SEMA 2017

WELCOME

Dear Esteemed Members and Colleagues,

The Spanish Environmental Mutagenesis and Genomics Society (SEMA) extends a warm invitation to you to participate in the 28th Scientific Meeting, marking a historic occasion as it ventures beyond borders into the captivating landscapes of Portugal. This congress, entitled “Bridging Borders: Exploring Mutagenesis and Genomics in the Heart of Vila Real, Portugal”, will unfold in the picturesque city of Vila Real, Portugal, from June 26th to 28th, 2024.

Embarking on this inaugural journey to Portugal, we envision a platform that fosters scientific exchange and strengthens the bonds of collaboration between the scientific communities of Spain and Portugal. The proximity of the congress venue to the Spanish border provides a unique opportunity for direct and enriching interactions among scientists.

As we meticulously craft the scientific program, we aim to present a comprehensive and engaging itinerary that caters to the interests of both academia and industry. The program will showcase recent findings and advances in mutagenesis and environmental genomics, providing a holistic perspective on the latest developments in these dynamic disciplines.

With its historic charm and natural beauty, Vila Real sets the stage for a congress that promises to be intellectually stimulating and an unforgettable experience. This vibrant city invites you to explore its rich cultural heritage, picturesque landscapes, and the warmth of its people.

Join us in Vila Real for a congress that goes beyond scientific discussions, creates lasting memories, and inspires new ideas. Let us come together to celebrate the spirit of scientific inquiry and collaboration in this beautiful corner of the world.

We eagerly anticipate your presence and contribution to make the 28th SEMA Scientific Meeting a resounding success.

Warm regards,

SEMA Executive Committee

LOCAL ORGANIZING COMMITTEE

  • Isabel Gaivão
    Universidade de Trás-os-Montes e Alto Douro, Vila Real

Contact: igaivao@utad.pt | Tel. +351 910500469
Departamento de Genética e Biotecnologia
Blocos Laboratoriais, UTAD
5000-801 Vila Real
Portugal

  • Fernanda Leal
    Universidade de Trás-os-Montes e Alto Douro, Vila Real
  • Sara Gonçalves
    Universidade de Trás-os-Montes e Alto Douro, Vila Real
  • Raquel Chaves
    Universidade de Trás-os-Montes e Alto Douro, Vila Real
ORGANIZING COMMITTEE
  • Amaya Azqueta Oscoz
    Universidad de Navarra, Pamplona
  • Antonio Guzmán Cano
    Alexion Pharmaceuticals, Barcelona
  • Alba Hernández Bonilla
    Universitat Autònoma de Barcelona
  • Isabel Gaivão
    Universidade de Trás-os-Montes e Alto Douro, Vila Real
  • Óscar Herrero Felipe
    Universidad Nacional de Educación a Distancia, Madrid
  • Blanca Laffon Lage
    Universidade da Coruña
  • María Teresa Roldán-Arjona
    Universidad de Córdoba
  • Luisa María Sierra Zapico
    Universidad de Oviedo
  • Raquel Chaves
    Universidade de Trás-os-Montes e Alto Douro, Vila Real

SCIENTIFIC COMMITTEE

  • Amaya Azqueta Oscoz
    Universidad de Navarra, Pamplona
  • Antonio Guzmán Cano
    Alexion Pharmaceuticals, Barcelona
  • Alba Hernández Bonilla
    Universitat Autònoma de Barcelona
  • Isabel Gaivão
    Universidade de Trás-os-Montes e Alto Douro, Vila Real
  • Óscar Herrero Felipe
    Universidad Nacional de Educación a Distancia, Madrid
  • Blanca Laffon Lage
    Universidade da Coruña
  • María Teresa Roldán-Arjona
    Universidad de Córdoba
  • Luisa María Sierra Zapico
    Universidad de Oviedo

INVITED SPEAKERS

Filomena Adega

University of Trás-os-Montes and Alto Douro (Portugal)
More info ...

Filomena Adega is Assistant Professor in the Department of Genetics at the University of Trás-os-Montes and Alto Douro, the Coordinator of the Service Provider Unit, Genetics4U, at UTAD and an integrated member of the Institute of Biosystems and Integrative Sciences, BioISI-Polo UTAD. Has participated or is participating in scientific research projects in the areas of Comparative Genomics, Chromosome Architectures, Genome adaptation, evolution and disease impacted by the ‘Satellitome’ and the ‘Mobilome’, scientific areas in which she has been publishing since 2002. She actively collaborates with various research groups around the world in her areas of expertise. To date, has supervised or co-supervised eight PhD, 21 MSc and 39 undergraduate students, contributing to the increase of highly specialized human resources. She is responsible for the laser microdissection station, the in vitro animal cell culture and the confocal microscopy unit facilities of UTAD’s CytoGenomics Lab.

Carmen Jerónimo

Instituto Português de Oncologia (Portugal)
More info ...

Carmen Jerónimo, is Director of the IPO Research Center (since 2021), Scientific Coordinator of the Porto IPO Biobank (since 2016) and Coordinator of the Epigenetics and Cancer Biology Group (since 2008).
She obtained a Degree in Biology (1994), Master’s in Oncology (1998), PhD in Biomedical Sciences (2001) and Aggregation in Pathology and Molecular Genetics (2011) at Porto University.

She developed his doctoral project within the scope of the GABBA Doctoral Program at the Johns Hopkins University School of Medicine (JHU), in Baltimore, MD, USA, working on genetic and epigenetic alterations in prostate cancer. She was a post-doctoral fellow in collaboration with JHU (2001-2004) and a guest researcher at IPO Porto (2004-2008).

Her research at the IPO Porto Research Center focuses on characterizing the epigenome of tumor cells, as well as identifying the functional changes involved in the dysregulation of cellular epigenetic homeostasis. In the context of Personalized Medicine, she works on the development of new epigenetic cancer biomarkers based on liquid biopsies, as well as drug discovery based on the modulation of epigenetic aberrations. Due to the relevance that Immuno-oncology has demonstrated in recent years, it also investigates the modulation of the epigenetic expression of biomolecules involved in immune regulation, aiming to improve immunotherapeutic strategies by combining with epi-drugs. More recently, she has begun to address the contribution of dysregulated non-coding RNAs and their interaction with other epigenetic mechanisms in malignant transformation.
She is currently the Clinical Epigenetics Section Editor and Associate Editor of the International Journal of Molecular Sciences and Epigenomes. She regularly acts as an ad hoc reviewer of several scientific journals and grants/research projects from national agencies (FCT Investigator Call 2013 and 2015) and international agencies (2003-Health Research Board- HRB-IR; 2006-Associazione Italiana per la Ricerca sul Cancro; 2015-FWF Austrian Science Fund;
She has authored or co-authored more than 250 international scientific publications, including 11 book chapters and 54 review articles (H-index 55; Web of Science 12/2023), including first quartile (Q1) journals, including: Clin Cancer Res , Cancers, Cancer Letters, Cell Death Dis, Br J Cancer, Eur J Cancer, J Cell Mol Med, J Hematol Oncol, JNCI, Mol Cancer, Mol Oncol, Nat Commun, Oncogene and PNAS.

Carina Ladeira

University of Lisbon (Portugal)
More info ...

PhD in Biology with specialization in Genetics and Master in Human Molecular Biology from the Faculty of Sciences of the University of Lisbon, degree in Biomedical Laboratorial Sciences. Adjunct Professor at School of Health Technology School of Lisbon – Polytechnic Institute of Lisbon. She is part of several international and national projects, author of 1 book, 8 book chapters, around 40 scientific articles in journals with an impact factor, 50 oral communications and 100 poster communications. Her research interests are in human biomonitoring, genetic toxicology, environmental and occupational exposure, among others subjects. She was a member of scientific and organizing committees for several national and international events, as well as moderating tables at scientific events.

Henriqueta Louro

University of Lisbon (Portugal)
More info ...

HL holds a Ph.D in Public Health – Environmental and Occupational Health (ENSP, Nova University of Lisbon, Portugal) and is graduated in Biochemistry (Faculty of Sciences, Lisbon University). She works as research scientist in the field of genetic toxicology, since 1997, involved in studies in human biomonitoring and nanotoxicology, with participation in European projects such as Nanogenotox, Nanoreg, HBM4EU, and the ongoing European Partnership for the Assessment of Risks from Chemicals (PARC). She is a member the cross-cutting Working Groups on Genotoxicity of the European Food Safety Authority (EFSA), Nanotechnologies and NAMs. As of 2023, is a genotoxicity expert for Scientific Committee for Consumer Safety (SCCS).

Ana Teresa Reis

Institute of Public Health, University of Porto (Portugal)
More info ...

Ana Teresa Reis is a researcher at the Nanomaterials: Safety and Health Lab, part of the Integrative and Translational Research in Population Health (ITR) Associated Laboratory / Instituto de Saúde Pública da Universidade do Porto. Her research focuses on understanding the biological effects of human exposure to mixtures of legacy and emerging environmental contaminants, using both in vitro and in vivo models, and in the development of novel approaches to predict the toxicity of these contaminants. In this area, she coordinates projects NanoLegaTox (POCI-01-0145-FEDER-029651) and MixIng-Tox (2022.03491.PTDC).

ABSTRACT SUBMISSION

The deadline for submitting your abstract for the SEMA 2024 Congress is May 15th, 2024.

Please download here the template to prepare your abstract. Follow the instructions provided in the template and submit your abstract through our abstract submission form.

You can enter the form via the button below.

Authors will be notified of acceptance by May 29th, 2024, at the latest. The communication will be finally accepted only if the main author registers for the congress.

TOPICS

Genomic instability, mutagenesis and disease
Biomarkers and biological monitoring
DNA damage, repair and protection
Emerging pollutants
Gene expression and epigenetics

ORAL PRESENTATIONS

All oral presentations except for invited lectures should last 10 minutes each + time allocated to 2-3 questions. Oral presenters are requested not to exceed their allocated time. The time schedule will be strictly followed by the chair.

Oral presenters are requested to bring their presentation files on a flash drive (USB memory stick).

All presentations should meet commonly compatible format (PPT, PPTX, PDF).

SUMMARIZE YOUR PhD THESIS

For the first time in this edition, SEMA is organizing a competition for speakers who want to present their doctoral thesis briefly. Those presenting an oral communication at the congress and working on their doctoral thesis or obtaining their doctorate a maximum of 2 years ago may participate with an extra presentation.

Interested candidates should check the corresponding option on the abstract submission form and indicate the title of their doctoral thesis. The Organising Committee will select the candidates from all the applications received, and each candidate will have 5 minutes to present an overview of their thesis work.

Presenters are requested to bring their presentation files on a flash drive (USB memory stick).

All presentations should meet commonly compatible format (PPT, PPTX, PDF).

REGISTRATION

The online registration for the SEMA 2024 Congress is open now.

You can enter the registration form via the button below.

REGISTRATION FEES

Student ***
SEMA member
Other
Accompanying person ****
EARLY *
€130
€180
€220
€55
REGULAR **
€150
€200
€250
€55

* Early fee is valid for payments made before June 1st 7th, 2024.
** Regular fee is valid for payments made from June 1st 7th, 2024.
*** Only valid for full-time students who have not finished their studies yet before the congress starts.

Registration fee includes:

  • Admission to SEMA 2024 (26-28 June)
  • Coffee breaks
  • Lunch on Thursday 27th
  • Social event and congress dinner on Thursday 27th

**** Accompanying fee includes:

  • Social event and congress dinner on Thursday 27th

PAYMENT METHODS

Use our payment form to pay your registration fee. It includes a secure payment gateway powered by Stripe.

Alternatively, you can pay by BANK TRANSFER, indicating your name and surname in the operation concept in the form «SEMA 2024 Name Surname«. Please send us the proof of the transfer by e-mail to sema@mutagenesisambiental.com.

SEMA bank account details:

  • Sociedad Española de Mutagénesis Ambiental
  • SWIFT/BIC: OPENESMM
  • IBAN: ES9400730100580505719517

Bank charges are the responsibility of the participant and should be paid in addition to the registration fees.

SPONSORS

Share This